Pentostatin | |
---|---|
Trade Name | Nipent |
Orphan Indication | Cutaneous T-cell lymphoma |
USA Market Approval | USA |
USA Designation Date | 1998-03-27 00:00:00 |
Sponsor | SuperGen, Inc.;4140 Dublin Blvd., Suite 200;Dublin, California, 94568 |
Related Access Program